Report
Letter from the Board of Directors
Key figures
Company profile
Sales and markets
Financial and sustainability discussion
The Novozymes stock
About the report
Outlook
Letter from the CEO
Long-term targets
Expectations for 2010
Management
Board of Directors & Executive Management
Corporate governance
Risk management
Risk factors
Accounts
Accounting policies
Income statement
Statement of comprehensive income
Balance sheet
Statement of shareholders' equity
Statement of cash flows and financial resources
Environmental and social data
Notes
Group companies
Statements
Financial statements for Novozymes A/S
Supplementary reporting
GRI indicators
Site data
Global Compact - Communication on progress
LCA studies
To main page
|
Download report
|
Privacy
|
Legal
|
Sitemap
LATEST NEWS FROM NOVOZYMES.COM
Piedmont Biofuels and Novozymes to unveil new technology
15.07.2010
Novozymes, the world’s leading producer of industrial enzymes, and Piedmont Biofuels, leaders in biofuels in North Carolina, tomorrow will unveil a new pilot plant to demonstrate an improved technological process for the production of biodiesel.
Novozymes Biopharma to supply GMP albucult® for use in medical devices
08.07.2010
The agreement will result in the launch of the first Class III medical device (used in high-risk applications such as pacemakers and heart valves) containing albucult.
Bookmarked pages (0)
›
View bookmarked pages
CFO Benny Loft on the overall results for the year
EVP Peder Holk Nielsen on biofuels and detergents
EVP Thomas Videbæk on the bio-based society
SEE ALL VIDEOS
›
KEYWORDS
Accounts
Ambitions
Biofuel
BPI
Climate
CO
2
Detergents
Environment
Global Compact
GRI
Growth
Investments
LCA
Markets
Microorganisms
Resources
Results
Sales
Social responsibility
Stock
Sustainability
Targets
